Colorectal cancer us, Cancer screening – equal treatment and access


Ki is a marker of cell proliferation associated with a low survival in colorectal cancer patients.

Its expression is increased in patients with Dukes C or D colorectal cancer versus those in stage A or B. The purpose of the study is to evaluate the immunohistochemical expression of the Ki marker in colorectal adenocarcinomas.

The study colorectal cancer us performed on a group of 28 patients diagnosed with rectal cancer.

colorectal cancer us medicamente pentru oxiuri

We made the histopathological and immunohistochemical evaluation of patients in the study group. The evaluation was performed on the sections colorectal cancer us with hematoxylin-eosin, and for mucinous forms, on sections stained with alcian blue.

enterobioză pozitivă la copii

The topography of the Ki reaction is strictly nuclear, evident in areas with intense proliferative activity. In cases with a strong positive response to Ki, the prognosis is worse, with invasion of the perirectal tissues and metastases.

Accepted Apr Copyright © The Authors. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. This article has been cited by other articles in PMC. Abstract Given the abundance of misreporting about diet and cancer in the media and online, cancer survivors are at risk of misinformation.

The lack of Ki expression in nearby neoplastic tissues suggests that cancerous tissue proliferates in a pathway that it is not correlated with adjacent tissues. The Ki could be useful in the prognosis of patients with colorectal cancer.

ossiuri bambini rimedi naturali human papillomavirus vaccine gsk

Keywords: colorectal cancer; Ki immunohistochemical expression; prognosis Issue:Volume 70, Issue 1 Pages: